Full audit trail review is rarely practical
Audit trails can be massive. Reviewing everything is not realistic, and auditors know that. What they expect is a rational, risk-based sampling strategy with evidence of execution and follow-up.
A defensible sampling strategy
Sample by event type. Prioritize approvals, edits to critical fields, permission changes, and deletions.
Sample by user risk. Admin accounts, high-privilege roles, new users, and users with unusual activity.
Sample by time. After-hours activity, month-end processing, and periods after major changes.
Sample by exceptions. Events tied to deviations, incidents, or system alerts.
Evidence you must keep
Export used for review, sampling rationale, findings, and follow-up actions. Sampling is defensible when it is documented and consistently applied.
In recent years, validation processes across the pharmaceutical industry have been undergoing a major transformation. Workflows that were traditionally managed through paper documentation, spreadsheets and manual review cycles are increasingly moving toward digital validation platforms. As a result, life sciences organizations often evaluate solutions such as Kneat, Validfor, ValGenesis, MasterControl and Veeva when modernizing validation lifecycle management and compliance documentation.

